{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T10:00:17Z","timestamp":1780912817273,"version":"3.54.1"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI23C016000"],"award-info":[{"award-number":["HI23C016000"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002541","name":"Pohang University of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002541","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejmech.2025.118323","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:10:22Z","timestamp":1761783022000},"page":"118323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["Pyrrolopyrimidines: A promising scaffold for the development of novel cathepsin K inhibitors"],"prefix":"10.1016","volume":"302","author":[{"given":"Jusuk","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Go-Ni","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Jin","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Jung","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hoon","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Hyun","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118323_bib1","article-title":"Prevalence of osteoporosis and related lifestyle and metabolic factors of postmenopausal women and elderly men: a cross-sectional study in Gansu province, Northwestern of China","volume":"96","author":"Tian","year":"2017","journal-title":"Med. (Baltim.)"},{"key":"10.1016\/j.ejmech.2025.118323_bib2","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1172\/JCI27071","article-title":"Pathogenesis of osteoporosis: concepts, conflicts, and prospects","volume":"115","author":"Raisz","year":"2005","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2025.118323_bib3","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2174\/13894501113149990202","article-title":"Cathepsin K inhibitors: a novel target but promising approach in the treatment of osteoporosis","volume":"14","author":"Helali","year":"2013","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ejmech.2025.118323_bib4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.semcancer.2015.08.010","article-title":"Complexity of cancer protease biology: cathepsin K expression and function in cancer progression","volume":"35","author":"Verbovsek","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ejmech.2025.118323_bib5","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1359\/jbmr.091035","article-title":"Odanacatib, a cathepsin-K inhibitor for osteoporosis: a two-year study in postmenopausal women with low bone density","volume":"25","author":"Bone","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ejmech.2025.118323_bib6","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bone.2006.07.015","article-title":"A highly potent inhibitor of cathepsin K (relacatib) reduces biomarkers of bone resorption both in vitro and in an acute model of elevated bone turnover in vivo in monkeys","volume":"40","author":"Kumar","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.ejmech.2025.118323_bib7","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1007\/s00198-011-1529-x","article-title":"A cathepsin K inhibitor, stimulates periosteal bone formation in monkeys","volume":"22","author":"Jerome","year":"2011","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.ejmech.2025.118323_bib8","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/jbmr.341","article-title":"Safety and efficacy of the cathepsin K inhibitor ONO-5334 in postmenopausal osteoporosis: the OCEAN study","volume":"26","author":"Eastell","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ejmech.2025.118323_bib9","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S2213-8587(19)30346-8","article-title":"Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT extension study","volume":"7","author":"McClung","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.ejmech.2025.118323_bib10","doi-asserted-by":"crossref","first-page":"7535","DOI":"10.1021\/jm0504961","article-title":"Lysosomotropism of basic cathepsin K inhibitors contributes to increased cellular potencies against off-target cathepsins and reduced functional selectivity","volume":"48","author":"Falgueyret","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118323_bib11","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1002\/cbic.200600149","article-title":"The consequences of lysosomotropism on the design of selective cathepsin K inhibitors","volume":"7","author":"Black","year":"2006","journal-title":"Chembiochem"},{"key":"10.1016\/j.ejmech.2025.118323_bib12","doi-asserted-by":"crossref","first-page":"8447","DOI":"10.1021\/bi025638x","article-title":"Selective inhibition of the collagenolytic activity of human cathepsin K by altering its S2 subsite specificity","volume":"41","author":"Lecaille","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2025.118323_bib13","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bbapap.2011.10.002","article-title":"Cysteine cathepsins: from structure, function and regulation to new frontiers","volume":"1824","author":"Turk","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2025.118323_bib14","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s42003-023-04772-8","article-title":"Proteomic data and structure analysis combined reveal interplay of structural rigidity and flexibility on selectivity of cysteine cathepsins","volume":"6","author":"Tu\u0161ar","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ejmech.2025.118323_bib15","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1039\/c2ob06899k","article-title":"Solid-phase synthesis of tetrasubstituted pyrrolo[2,3-d]pyrimidines","volume":"10","author":"Lee","year":"2012","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2025.118323_bib16","unstructured":"Virtual computational chemistry laboratory (VCCLAB), http:\/\/www.vcclab.org, 2005."},{"key":"10.1016\/j.ejmech.2025.118323_bib17","unstructured":"Molinspiration property calculation service, http:\/\/www.molinspiration.com, 2002."},{"key":"10.1016\/j.ejmech.2025.118323_bib18","unstructured":"Prediction of ADMET\/Tox, https:\/\/preadmet.webservice.bmdrc.org, 2004."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425010888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425010888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T09:02:37Z","timestamp":1780909357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425010888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":18,"alternative-id":["S0223523425010888"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118323","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pyrrolopyrimidines: A promising scaffold for the development of novel cathepsin K inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118323","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118323"}}